(R)-N-Boc-Piperidine-2-methanol

Catalog No. :
ACLPZM258
CAS No. :
134441-61-5
Molecular Formula :
C11H21NO3
Molecular Weight :
215.29

IUPAC Name:tert-butyl (R)-2-(hydroxymethyl)piperidine-1-carboxylate

(R)-N-Boc-Piperidine-2-methanol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g95%$115.00Login to see priceIn stockInquiry
100g95%$416.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-N-Boc-Piperidine-2-methanol
IUPAC Nametert-butyl (R)-2-(hydroxymethyl)piperidine-1-carboxylate
MDL No.MFCD04973120
Molecular FormulaC11H21NO3
Molecular Weight215.29
SMILESC(=O)(OC(C)(C)C)N1CCCC[C@@H]1CO
InChI KeyPZTAGFCBNDBBFZ-SECBINFHSA-N
Synonym134441-61-5 | (R)-N-Boc-piperidine-2-methanol | (R)-1-N-Boc-2-Hydroxymethylpiperidine | tert-butyl (2R)-2-(hydroxymethyl)piperidine-1-carboxylate | (R)-N-Boc -piperidine-2-methanol | (R)-tert-butyl 2-(hydroxymethyl)piperidine-1-carboxylate | MFCD04973120 | (R)-1-BOC-2-
CAS No.134441-61-5
PubChem CID6933953

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACLPZM258 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXAZK735 route compound structure diagram
    ACXAZK73528697-17-8 In Stock
  2. Then
  3. ACLPZM258 route product structure diagram
    ACLPZM258134441-61-5 In Stock
Inquiry

2. ACLPZM258 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXAZK735 route compound structure diagram
    ACXAZK73528697-17-8 In Stock
  4. Plus
  5. ACUXNZ518 route compound structure diagram
    ACUXNZ51829892-37-3 In Stock
  6. Then
  7. ACLPZM258 route product structure diagram
    ACLPZM258134441-61-5 In Stock
Inquiry

Comments (0)